Researchers at UCLA's Jonsson Comprehensive Cancer Center (JCCC) have found that mice made obese by being given high-calorie, high-fat diets (HFCD) developed abnormally high numbers of lesions known as pancreatic intraepithelial neoplasias (PanINs), which are known to be precursors to pancreas cancer. This is the first study to show a direct causative link in an animal model between obesity and risk of this deadly cancer.
The study was led by Dr. Guido Eibl, JCCC member and professor -in-residence in the department of surgery at David Geffen School of Medicine. It was published in the journal Cancer Prevention Research.
Cancer of the pancreas (scientifically known as pancreatic ductal adenocarcinoma or PaCa) is one of the most deadly forms of the disease in humans. Overall five-year survival rates are approximately three to five percent and the average survival period after diagnosis is just four to six months. It is a particularly aggressive disease and often beyond the point of effective treatment by the time symptoms appear. Current treatments are limited in number and effectiveness, thus researchers are turning to prevention strategies to try to make headway against the disease before it reaches advanced stages. Previous research in the study of the disease in large populations has strongly supported a positive association between obesity and increased risk of PaCa, but no studies recapitulated human PaCa in animals. The availability of genetically engineered model mice that have the same genetic mutation found in human pancreas cancer patients (the KR as mutation) has made study of the possible causes more feasible, because changes in the mouse metabolism caused by obesity are similar to those in humans.
Dr. Eibl and colleagues set out to develop diet-induced obesity and development of pancreas cancer in a set of mice and then compare them to another set of mice that are genetically identical but not given a high-fat, high-calorie diet. Obesity in these mice resembles several important clinical features of human obesity such as weight gain and disturbance of metabolism, and this mouse model was ideal for unraveling any underlying biological mechanisms of pancreas cancer that are put in motion by obesity.
The researchers also set parameters to assess the impact of the effects of the high-fat, high-calorie diet on mouse pancreas tissue, such as increased inflammation and other biological signs that indicate pancreas problems. These indicators were measured and used to create an overall score (pancreatitis score) to indicate negative effects on the pancreas. They then conducted pathology tests on mouse pancreas tissue to determine how many PanIN precursor lesions had developed.
Mice that ate the normal diet gained an average of approximately 7.2 grams, plus or minus approximately 2.8 grams over 14 months. Mice that ate the high-fat, high-calorie diet gained an average of 15.9 grams, plus or minus 3.2 grams. Mice fed the normal diet had mostly normal pancreases with very few scattered PanIN lesions. Mice fed the high-fat, high-calorie diet had significantly more PanIN lesions and fewer overall healthy pancreases.
The study showed that the mice fed a diet high in fats and calories gained significantly more weight, had abnormalities of their metabolism and increased insulin levels, and had marked pancreatic tissue inflammation and development of PanIN lesions. These observations strongly suggest that such a diet leads to weight gain, metabolism disturbances, can cause pancreas inflammation and promotes pancreas lesions that are precursors to cancer.
"The development of these lesions in mice is very similar to what happens in humans," Dr. Eibl said. "These lesions take a long time to develop into cancer, so there is enough time for cancer preventive strategies, such as changing to a lower fat, lower calorie diet, to have a positive effect."
This research was supported by the National Institutes of Health, the US Department of Veterans Affairs, and Hirshberg Foundation for Pancreatic Cancer Research.
UCLA's Jonsson Comprehensive Cancer Center has more than 240 researchers and clinicians engaged in disease research, prevention, detection, control, treatment and education. One of the nation's largest comprehensive cancer centers, the Jonsson center is dedicated to promoting research and translating basic science into leading-edge clinical studies. In July 2013, the Jonsson Cancer Center was named among the top 12 cancer centers nationwide by U.S. News & World Report, a ranking it has held for 14 consecutive years. For more information on the Jonsson Cancer Center, visit our website at http://www.cancer.ucla.edu.
The above post is reprinted from materials provided by University of California, Los Angeles (UCLA), Health Sciences. Note: Materials may be edited for content and length.
Cite This Page: